1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. KEROS THERAPEUTICS INC
Keros Therapeutics Inc XNAS: KROS

Keros Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Mid-range Performer
about

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet m...

Read More
16.04 0.42 (2.69%)
77.84% Fall from 52W High
225.0K
XNAS Volume

XNAS 18 Sep, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Durability score
High Financial Strength
55.6 / 100
Valuation Score
Mid Valuation
40.3 / 100
Momentum Score
Technically Neutral
52.9 / 100
Mid-range Performer These stocks are with strong quality. Their reasonable financials and technical aspects successfully gather investor's interest. View Similar Embed DVM
Analyst Price Target
23
1Yr Price target upside is 43%
8 analysts

17

S

5

W

1

O

2

T

SWOT Analysis

Keros Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..